Neofast-S 150 mg (Tablet)
Unit Price: ৳ 2.50 (10 x 10: ৳ 250.00)
Strip Price: ৳ 25.00
Medicine Details
Category | Details |
---|---|
Generic | Ranitidine hydrochloride |
Company | Incepta pharmaceuticals ltd |
Title
- Neofast-S Tablet
Categories
- Medicine
- Gastrointestinal
- Ulcer Treatment
- H2 Receptor Antagonist
DosageForm
Tablet, Syrup, IV Injection, IV Infusion
Indications
- Active duodenal ulcer treatment
- Benign gastric ulcer treatment
- Prevention of ulcer associated with non-steroidal anti-inflammatory agents
- Post-operative stress ulcer treatment
- Zollinger-Ellison Syndrome treatment
- Gastroesophageal reflux disease (GERD) treatment
- Gastrointestinal hemorrhage treatment
- Recurrent hemorrhage treatment in patients with bleeding peptic ulcer
- Pre-anesthesia prophylaxis for acid aspiration
- Episodic dyspepsia treatment
Pharmacology
Competitively blocks histamine at H2-receptors to inhibit gastric acid secretion
Interaction
- Delayed absorption and increased peak serum concentration with propantheline bromide
- Minimally inhibits hepatic metabolism of certain drugs
- May alter absorption of pH-dependent drugs
- Reduces bioavailability with antacids
Contraindications
Hypersensitivity to Ranitidine
SideEffects
- Altered bowel habit
- Dizziness
- Rash
- Tiredness
- Reversible confusional states
- Headache
- Decreased blood counts
- Muscle or joint pain
PregnancyAndLactation
- Pregnancy: Crosses placenta, caution advised
- Lactation: Excreted in human breast milk, caution advised
PrecautionsAndWarnings
Reduced dosage for impaired renal and hepatic function
UseInSpecialPopulations
- ElderlyPatients: Similar ulcer healing rates as in younger patients
OverdoseEffects
Specific action, no particular problems expected, supportive therapy recommended
TherapeuticClass
H2 receptor antagonist
Reconstitution
Specific reconstitution guidelines for different administration methods
StorageConditions
Cool, dry place; protect from light